In recent times, many medications and injections that promise rapid weight loss have become widely available, leading many individuals to rely on them to shed excess pounds. However, a report by the *New York Post* has revealed that some of these popular weight loss drugs may lead to sudden vision loss.
اضافة اعلان
The report shared the story of 56-year-old James Norris, who experienced gradual vision loss after using the medication *Mounjaro* in March 2023 to help lose weight.
The report confirmed that James successfully lost 40 kilograms over the course of a year while using *Mounjaro*. His health improved, and he was able to stop taking medications for high blood pressure and cholesterol.
In March 2024, Norris's doctor increased his dosage of *Mounjaro* to 2.5 milligrams (from an initial dose of 1.5 milligrams). One morning, he woke up to find his vision in his left eye had become blurry. Two weeks later, the vision in his right eye began to blur as well.
Norris described his experience, stating: "After undergoing a CT scan and visiting a neuro-ophthalmologist, I was diagnosed with ischemic optic neuropathy," a condition where the optic nerve loses its blood supply, leading to sudden vision loss.
Despite stopping *Mounjaro* in July 2024, Norris continues to suffer from severe vision impairment.
Robert King, Norris’s attorney, mentioned that his office had received hundreds of lawsuits related to weight loss medications and their link to vision loss.
In January of this year, researchers from the *John A. Moran Eye Center* at the *University of Utah* published a study indicating that patients who had taken medications containing *semaglutide* or *tirzepatide*, two active ingredients found in some weight loss drugs, developed conditions that affected the optic nerve and caused blindness.
